These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

292 related items for PubMed ID: 3762808

  • 1. Significance of carcinoembryonic and tissue polypeptide antigen determination in the diagnosis of metastases in breast cancer.
    Kausitz J, Hupka S, Makaiová I, Michalíková B, Urbanová M, Bohunický L, Belovicová C.
    Neoplasma; 1986; 33(4):471-6. PubMed ID: 3762808
    [Abstract] [Full Text] [Related]

  • 2. Differential immunocytochemical localization of tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA) in breast cancer.
    Björklund V, Björklund B.
    Cancer Detect Prev; 1983; 6(1-2):193-8. PubMed ID: 6883380
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Tissue polypeptide and carcinoembryonic antigens in patients with breast cancer].
    Polevaia EB, Tkacheva GA, Ivanov VM, Koposova TL.
    Vopr Onkol; 1984; 30(3):9-13. PubMed ID: 6710954
    [Abstract] [Full Text] [Related]

  • 6. Human tissue polypeptide antigen in breast cancer.
    Nemoto T, Constantine R, Chu TM.
    J Natl Cancer Inst; 1979 Dec; 63(6):1347-50. PubMed ID: 292806
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Combined use of carcinoembryonic antigen and tissue polypeptide antigen in oncologic therapy and surveillance.
    Lüthgens M, Schlegel G.
    Cancer Detect Prev; 1983 Dec; 6(1-2):51-9. PubMed ID: 6883393
    [Abstract] [Full Text] [Related]

  • 10. [Clinical study of the measurement of tissue polypeptide antigen in patients with breast cancer].
    Fukunaga M, Otsuka N, Yanagi M, Sone T, Muranaka A, Yanagimoto S, Tomomitsu T, Morita R, Ohama T, Sonoo H.
    Gan No Rinsho; 1985 Jul; 31(8):923-8. PubMed ID: 4032770
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comparison of serum CEA, PHI, and TPA as tumor markers in breast cancer patients.
    Paulick R, Caffier H, Paulick M.
    Cancer Detect Prev; 1987 Jul; 10(3-4):197-203. PubMed ID: 3568016
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Changes in carcinoembryonic antigen and tissue polypeptide antigen in monitoring the post-operative course of some tumor types].
    Ciaccio B, Caponi A, Cappetti P, Fanciullacci A, Bartoli P, Berti P.
    Quad Sclavo Diagn; 1985 Jun; 21(2):199-205. PubMed ID: 4080962
    [Abstract] [Full Text] [Related]

  • 18. [A comparative evaluation of tumor markers (TPA and CEA) in various malignant neoplasms at an advanced stage].
    Meregalli M, Antoniazzi V, Torchio G, Colombo E, Bocchi M, Sonzini E, Lino S.
    Minerva Med; 1989 Apr; 80(4):345-7. PubMed ID: 2725935
    [Abstract] [Full Text] [Related]

  • 19. The clinical significance of tissue polypeptide antigen in breast cancer patients.
    Mross K, Bandlow G.
    Anticancer Res; 1986 Apr; 6(2):223-5. PubMed ID: 3707059
    [Abstract] [Full Text] [Related]

  • 20. [Advantages and limitations of combined assays of 4 serum markers in various types of malignant neoplasms].
    Lanza E, Coda C, Ramella S, Ciambellotti E, Moro G, Cartia GL.
    Minerva Med; 1986 Sep 15; 77(34-35):1521-5. PubMed ID: 3463886
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.